Assay News and Research

RSS

Women with increased levels of M-llerian inhibiting substance are at risk of breast cancer

Women with increased levels of M-llerian inhibiting substance (MIS), best known for regulating in utero sexual differentiation in boys, may be at a greater risk for breast cancer, according to a new study published online October 9 in the Journal of the National Cancer Institute.

12 Oct 2009

Manual microdissection to remove biopsy cavities from breast cancer specimens essential

Genomic Health, Inc. today announced results from a study demonstrating the critical role of manual microdissection to remove all biopsy cavities from breast cancer specimens. Genomic Health's Oncotype DX is the only commercially available breast cancer test that employs manual microdissection following review by a board certified surgical pathologist with breast expertise to predict a patient's benefit from chemotherapy and risk of disease recurrence.

9 Oct 2009

FDA Advisory Committee approves use of Selzentry tablets in combination with HIV therapy

Pfizer Inc. announced today that the U.S. Food and Drug Administration’s (FDA) Antiviral Drugs Advisory Committee voted (10 to 4) to recommend the approval of Selzentry (maraviroc) tablets for use in treatment-naïve adult patients with CCR5-tropic HIV-1 virus as part of combination therapy.

9 Oct 2009

TargetEx to be the coordinator for CancerGrid consortium

TargetEx llc, Budapest announced today that the Research Directorate General of the Commission of the European Communities approved the transfer of the coordinator responsibilities of the European Cancer Research Consortium (CancerGrid) to TargetEx.

9 Oct 2009

Applied Neurosolutions provides update regarding its blood-based Alzheimer’s test

Applied NeuroSolutions, Inc.(www.AppliedNeuroSolutions.com), a biotechnology company focused on the development of products for the early diagnosis and treatment of Alzheimer's disease ("AD"), today confirmed, as previously disclosed in July 2009, that it has achieved sufficient analytical sensitivity to detect tau in serum patient samples.

9 Oct 2009

BioFocus to use DiscoveRx's GPCR screening assay and associated cell lines

DiscoveRx Corp. and BioFocus® announced today that they have signed a co-marketing agreement that allows BioFocus to perform screening on behalf of BioFocus’ customers using DiscoveRx PathHunter™ ß-Arrestin GPCR screening assay, HitHunter™ cAMP assays and associated cell lines.

9 Oct 2009

Dominion Diagnostics enhances laboratory testing procedure for chronic opioid pharmacotherapy

Only a short time after introducing its newly developed and validated tapentadol assay, Dominion Diagnostics (Dominion) is pleased to announce an important enhancement to another clinical laboratory test.

8 Oct 2009

New apoptosis detection kit for monitoring chromatin condensation

Enzo Biochem, Inc.’s Enzo Life Sciences division today announced the addition of a new apoptosis detection kit for monitoring chromatin condensation to its rapidly expanding CELLestial™ product line for live cell analysis.

7 Oct 2009

Fully validated assay to detect the presence of Calicivirus 2117 in biological samples

BioReliance Corporation announced today that it has launched a fully validated assay which can sensitively detect the presence of Calicivirus 2117 in biological samples. The test is designed to provide manufacturers of biological therapeutics and other biologically based products the ability to detect this potential contaminant of mammalian cell culture based systems.

7 Oct 2009

AOAC Research Institute certifies Idaho's E.coli O157:H7 test

Idaho Technology, Inc. (ITI) has been granted Performance Tested Methods Status by the AOAC Research Institute (Certificate No. 100901) for its E.coli O157:H7 test used with the R.A.P.I.D.® LT Food Security System (FSS). The assay uses real-time PCR technology to identify the presence of E.coli O157:H7 in raw ground beef and uncooked spinach food samples.

7 Oct 2009

Promising alternative to use of live animals for drug testing

International Stem Cell Corporation, the first company to perfect a method of creating human “parthenogenetic” stem cells from unfertilized eggs, announces positive results of its collaboration with Absorption Systems to study ISCO’s stem-cell-derived human corneal tissue as an alternative to live animals for drug testing.

6 Oct 2009

$APP Pharmaceutical continues support of FDA's USP standards for unfractionated heparin$

APP Pharmaceutical continues support of FDA's USP standards for unfractionated heparin

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ:APCVZ), and the leading supplier of heparin sodium to the U.S. market, announced today its continued support of the US Food & Drug Administration (FDA) and medical community for the October 1, 2009 implementation of the new United States Pharmacopeia (USP) monograph change for unfractionated heparin.

3 Oct 2009

Co-marketing partnership between Enzo Life Sciences and BioTek Instruments

Enzo Biochem, Inc. announced today a co-marketing partnership between its Enzo Life Sciences subsidiary, a world leader in non-radioactive probe technology, and BioTek Instruments, a privately held global leader in the development, manufacture and sale of microplate instrumentation for drug discovery and life science applications, involving powerful, integrated solutions for high throughput live cell analysis.

3 Oct 2009

Epigentek Group releases SuperSense Methylated DNA Quantification kit

Epigentek Group Inc. today announced that it released the SuperSense(TM) Methylated DNA Quantification Kit to complete its line of methylated DNA quantification products. The SuperSense(TM) kit fluorometrically measures global DNA methylation shifts.

1 Oct 2009

Diamedix files a 510(k) premarket submission with the FDA for its Mago4S assay system

IVAX Diagnostics, Inc. announced today that its U.S. subsidiary headquartered in Florida, Diamedix Corporation, has filed a 510(k) premarket submission with the U.S. Food and Drug Administration (“FDA”) for its next -generation fully automated Enzyme-linked Immunosorbent Assay (“ELISA”) system for autoimmune and infectious disease testing, named the Mago®4S.

1 Oct 2009

Public lecture to highlight what causes cell division to go wrong and lead to cancer

University of Leicester research which substantially increases our understanding of what causes cell division to go wrong and lead to cancer will be highlighted in a public lecture at the University on Wednesday 14th October at 5.30-6.30pm.

1 Oct 2009

Meridian Bioscience Europe to distribute the BÜHLMANN Calprotectin test in Italy

Meridian Bioscience, Inc., Cincinnati, Ohio announced today that Meridian Bioscience Europe srl, Milan, Italy has signed an agreement with BÜHLMANN Laboratories AG, Schönenbuch, Switzerland for distribution in Italy of an innovative test for inflammatory conditions of the intestine, Quantum Blue® Calprotectin.

1 Oct 2009

Immunocellular Therapeutics' pilot study can help in early cancer detection

ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune-based therapies for the treatment of brain and other cancers, announced today results from its pilot study evaluating the cancer detection abilities of one of its lead monoclonal antibody product candidates, ICT-109. Data from this study demonstrated that ICT-109 had a statistically significant ability to discriminate between cancerous and non-cancerous samples, suggesting the potential to detect pancreatic and lung cancer in plasma and serum study sets.

30 Sep 2009

NIH awards DiscoveryBioMed a Phase 2 SBIR grant for research on hypertension and cystic fibrosis

DiscoveryBioMed, Inc. (DBM) today announced that it has been awarded a $750,000 Small Business Innovations Research (SBIR) Phase 2 grant by the National Institutes of Health (NIH) to continue the research into the discovery and development of small molecules to alleviate multiple chronic human diseases including cystic fibrosis (CF), hypertension and chronic kidney diseases with hypertension.

28 Sep 2009

Quintiles opens an expanded regional facility

To enhance service offerings throughout Europe, Quintiles Transnational Corp. today announced the opening of an expanded regional facility near Edinburgh, Scotland. The purpose-built facility consolidates three buildings into a single state-of-the-art complex.

28 Sep 2009

Assay News and Research

Women with increased levels of M-llerian inhibiting substance are at risk of breast cancer

Manual microdissection to remove biopsy cavities from breast cancer specimens essential

FDA Advisory Committee approves use of Selzentry tablets in combination with HIV therapy

TargetEx to be the coordinator for CancerGrid consortium

Applied Neurosolutions provides update regarding its blood-based Alzheimer’s test

BioFocus to use DiscoveRx's GPCR screening assay and associated cell lines

Dominion Diagnostics enhances laboratory testing procedure for chronic opioid pharmacotherapy

New apoptosis detection kit for monitoring chromatin condensation

Fully validated assay to detect the presence of Calicivirus 2117 in biological samples

AOAC Research Institute certifies Idaho's E.coli O157:H7 test

Promising alternative to use of live animals for drug testing

APP Pharmaceutical continues support of FDA's USP standards for unfractionated heparin

Co-marketing partnership between Enzo Life Sciences and BioTek Instruments

Epigentek Group releases SuperSense Methylated DNA Quantification kit

Diamedix files a 510(k) premarket submission with the FDA for its Mago4S assay system

Public lecture to highlight what causes cell division to go wrong and lead to cancer

Meridian Bioscience Europe to distribute the BÜHLMANN Calprotectin test in Italy

Immunocellular Therapeutics' pilot study can help in early cancer detection

NIH awards DiscoveryBioMed a Phase 2 SBIR grant for research on hypertension and cystic fibrosis

Quintiles opens an expanded regional facility

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News